Cello Health (CLL)

Sector:

Health Care

Index:

FTSE AIM All-Share

108.00p
   
  • Change Today:
    -2.50p
  • 52 Week High: 148.50
  • 52 Week Low: 101.00
  • Currency: UK Pounds
  • Shares Issued: 106.23m
  • Volume: 107,591
  • Market Cap: £114.73m
  • RiskGrade: 285

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth
1.45% above the market average1.45% above the market average1.45% above the market average1.45% above the market average1.45% above the market average
20% below the sector average20% below the sector average20% below the sector average20% below the sector average20% below the sector average
1yr Revenue Growth
11.36% below the market average11.36% below the market average11.36% below the market average11.36% below the market average11.36% below the market average
25.71% below the sector average25.71% below the sector average25.71% below the sector average25.71% below the sector average25.71% below the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield
15.4% below the market average15.4% below the market average15.4% below the market average15.4% below the market average15.4% below the market average
73.33% above the sector average73.33% above the sector average73.33% above the sector average73.33% above the sector average73.33% above the sector average
1yr DPS Growth
6.10% above the market average6.10% above the market average6.10% above the market average6.10% above the market average6.10% above the market average
Sector averageSector averageSector averageSector averageSector average

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
46.39% below the market average46.39% below the market average46.39% below the market average46.39% below the market average46.39% below the market average
84.62% below the sector average84.62% below the sector average84.62% below the sector average84.62% below the sector average84.62% below the sector average
Price Book Ratio
34.33% below the market average34.33% below the market average34.33% below the market average34.33% below the market average34.33% below the market average
31.43% above the sector average31.43% above the sector average31.43% above the sector average31.43% above the sector average31.43% above the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
1.78% below the market average1.78% below the market average1.78% below the market average1.78% below the market average1.78% below the market average
26.83% below the sector average26.83% below the sector average26.83% below the sector average26.83% below the sector average26.83% below the sector average
Price Chg 3m
32.81% above the market average32.81% above the market average32.81% above the market average32.81% above the market average32.81% above the market average
21.95% above the sector average21.95% above the sector average21.95% above the sector average21.95% above the sector average21.95% above the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
22.68% above the market average22.68% above the market average22.68% above the market average22.68% above the market average22.68% above the market average
43.59% below the sector average43.59% below the sector average43.59% below the sector average43.59% below the sector average43.59% below the sector average
Momentum 20
2.16% below the market average2.16% below the market average2.16% below the market average2.16% below the market average2.16% below the market average
28.21% below the sector average28.21% below the sector average28.21% below the sector average28.21% below the sector average28.21% below the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
20% below the market average20% below the market average20% below the market average20% below the market average20% below the market average
Sector averageSector averageSector averageSector averageSector average
ROCE
53.96% above the market average53.96% above the market average53.96% above the market average53.96% above the market average53.96% above the market average
18.18% above the sector average18.18% above the sector average18.18% above the sector average18.18% above the sector average18.18% above the sector average

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
24.88% above the market average24.88% above the market average24.88% above the market average24.88% above the market average24.88% above the market average
52.63% above the sector average52.63% above the sector average52.63% above the sector average52.63% above the sector average52.63% above the sector average
Forecast EPS
43.11% below the market average43.11% below the market average43.11% below the market average43.11% below the market average43.11% below the market average
37.5% below the sector average37.5% below the sector average37.5% below the sector average37.5% below the sector average37.5% below the sector average

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
43.08% above the market average43.08% above the market average43.08% above the market average43.08% above the market average43.08% above the market average
52.94% above the sector average52.94% above the sector average52.94% above the sector average52.94% above the sector average52.94% above the sector average
Operating Profit Loss
20.31% above the market average20.31% above the market average20.31% above the market average20.31% above the market average20.31% above the market average
31.58% above the sector average31.58% above the sector average31.58% above the sector average31.58% above the sector average31.58% above the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
25.74% above the market average25.74% above the market average25.74% above the market average25.74% above the market average25.74% above the market average
42.11% above the sector average42.11% above the sector average42.11% above the sector average42.11% above the sector average42.11% above the sector average
Cash
0.25% below the market average0.25% below the market average0.25% below the market average0.25% below the market average0.25% below the market average
2.7% below the sector average2.7% below the sector average2.7% below the sector average2.7% below the sector average2.7% below the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y
10.06% above the market average10.06% above the market average10.06% above the market average10.06% above the market average10.06% above the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average
Buys 1y
2.31% below the market average2.31% below the market average2.31% below the market average2.31% below the market average2.31% below the market average
20.00% above the sector average20.00% above the sector average20.00% above the sector average20.00% above the sector average20.00% above the sector average

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy
50.46% below the market average50.46% below the market average50.46% below the market average50.46% below the market average50.46% below the market average
60% below the sector average60% below the sector average60% below the sector average60% below the sector average60% below the sector average
Brokers Percent Neutral
37.39% above the market average37.39% above the market average37.39% above the market average37.39% above the market average37.39% above the market average
77.78% above the sector average77.78% above the sector average77.78% above the sector average77.78% above the sector average77.78% above the sector average

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Cello Health Market Data

Currency UK Pounds
Share Price 108.00p
Change Today -2.50p
% Change -2.26 %
52 Week High 148.50
52 Week Low 101.00
Volume 107,591
Shares Issued 106.23m
Market Cap £114.73m
RiskGrade 285

Cello Health Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
84.82% below the market average84.82% below the market average84.82% below the market average84.82% below the market average84.82% below the market average
13.51% below the sector average13.51% below the sector average13.51% below the sector average13.51% below the sector average13.51% below the sector average
Price Trend
37.46% above the market average37.46% above the market average37.46% above the market average37.46% above the market average37.46% above the market average
2.44% above the sector average2.44% above the sector average2.44% above the sector average2.44% above the sector average2.44% above the sector average
Income
16.9% below the market average16.9% below the market average16.9% below the market average16.9% below the market average16.9% below the market average
73.33% above the sector average73.33% above the sector average73.33% above the sector average73.33% above the sector average73.33% above the sector average
Growth
41.02% below the market average41.02% below the market average41.02% below the market average41.02% below the market average41.02% below the market average
55.56% below the sector average55.56% below the sector average55.56% below the sector average55.56% below the sector average55.56% below the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 1
Sell 0
Strong Sell 0
Total 2
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Cello Health Dividends

  Latest Previous
  Final Interim
Ex-Div 23-Apr-20 03-Oct-19
Paid 22-May-20 01-Nov-19
Amount 2.95p 1.15p

Trades for 27-Mar-2020

Time Volume / Share Price
16:24 66,760 @ 108.00p
16:25 5,400 @ 108.00p
16:24 50,000 @ 108.00p
16:21 5,400 @ 108.00p
14:22 918 @ 108.40p

Cello Health Key Personnel

CEO Mark Scott

Top of Page